
Monthly Obesity Drug Candidate Gets $1.5B Boost
Adults with obesity and related conditions may see more monthly treatment options as late-stage trials advance.
Live Poll
Do you think new weight-loss drugs will ever be affordable for you?
U.S. diabetes coverage follows treatment and monitoring developments, federal screening programs and the supply and pricing questions that determine access to care across the country. Reporting tracks approvals, research and the policy that shapes what patients can reach.

Adults with obesity and related conditions may see more monthly treatment options as late-stage trials advance.
Live Poll
Do you think new weight-loss drugs will ever be affordable for you?
November 20, 2026
Weekly Growth Shot Approved for Turner SyndromeChildren with Turner syndrome and their families now have a once-weekly option instead of daily growth hormone injections.
November 20, 2026
Hidden Triggers Cause Severe Allergic ReactionsPatients on compounded weight-loss drugs or venom allergy shots may face reactions that medication history and careful screening can help identify.
November 10, 2026
Type 2 Diabetes Rises Sharply Among Women Under 40Women under 40 with a history of gestational diabetes may want to ask their doctor about routine blood-sugar screening.
November 9, 2026
FDA Adds Vision-Loss Warning to GLP-1 Diabetes DrugsAdults taking GLP-1 receptor agonists now face a labeled warning about a rare condition that can cause sudden vision loss.
November 8, 2026
GLP-1 Drugs Linked to Lower Obesity-Cancer RatesAdults with Type 2 diabetes on GLP-1 medications had lower obesity-related cancer rates than those on insulin or sulfonylureas.
November 7, 2026
Normal BMI Doesn't Rule Out Diabetes RiskStudy finds South Asian adults in the U.S. face metabolic risk even at healthy body weight.
November 7, 2026
Liver Drug Eases Worry in Cirrhosis PatientsAdults with compensated MASH cirrhosis reported less worry after 52 weeks of resmetirom in a post hoc trial analysis.
November 6, 2026
Diabetic Children in Gaza Need Insulin AccessA children's educator's appeal highlights how Type 1 diabetes depends on reliable medication supply.
November 6, 2026
Drug Eases Blood Sugar and Weight in Type 1 DiabetesIn a small early trial, adults with type 1 diabetes and extra weight saw better glucose control and weight loss on the drug.
November 6, 2026
Lollipop Sensor Detects Acetaminophen in SalivaEarly tests on six adults suggest saliva could one day reveal acetaminophen levels without a blood draw.
Day to day, that means drug and device approvals, federal prevention and screening program updates, research into Type 1 and Type 2 management, and monitoring technology developments. New York, Los Angeles, Chicago, Houston and Phoenix are among the centers where diabetes program activity and clinical research draw national reporting. Insulin pricing and supply chain dynamics recur as recurring structural subjects, because they directly determine whether approved treatments are within reach. Insurance coverage rules and formulary decisions shape access to monitoring technology as much as clinical approvals do.